首页>Urologic oncology>Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma
Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma